| Q37875154 | A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies |
| Q64264319 | Alternatively Activated Macrophages Are Host Cells for and Reverse Anti-chlamydial Classically Activated Macrophages |
| Q37857345 | Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque |
| Q37874993 | Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris |
| Q37584947 | Are reactive oxygen species always detrimental to pathogens? |
| Q44210302 | Assessment of periodontal conditions and systemic disease in older subjects. II. Focus on cardiovascular diseases |
| Q34397021 | Assessment of subclinical atherosclerosis and cardiovascular risk. |
| Q39365197 | Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory |
| Q37877285 | Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae |
| Q37868385 | Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model |
| Q51726841 | Chlamydia pneumoniae and Cardiovascular Disease. |
| Q37877547 | Chlamydia pneumoniae and atherosclerosis: links to the disease process |
| Q62279926 | Chlamydia pneumoniae and atherosclerotic cardiovascular disease |
| Q35395485 | Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions |
| Q37852303 | Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways |
| Q37855399 | Chlamydia pneumoniae infection in patients after kidney transplantation treated with spiramycin. |
| Q37878378 | Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). |
| Q33927267 | Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo |
| Q37874834 | Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. |
| Q34009858 | Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro |
| Q37860795 | Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. |
| Q37856309 | Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation |
| Q37869989 | Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis |
| Q33609632 | Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? |
| Q37862676 | Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo |
| Q40622775 | Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism |
| Q37877605 | De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. |
| Q37243045 | Effects of Porphyromonas gingivalis lipopolysaccharide on the expression of key genes involved in cholesterol metabolism in macrophages |
| Q33987842 | Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. |
| Q33383817 | Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence |
| Q35144239 | Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. |
| Q35078469 | GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function |
| Q37866854 | Heat-inactivated C. pneumoniae organisms are not atherogenic. |
| Q36539539 | Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages |
| Q40564411 | In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells |
| Q37877535 | In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells |
| Q33871329 | Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease? |
| Q38370895 | Inflammation-induced foam cell formation in chronic inflammatory disease. |
| Q37860574 | Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology. |
| Q34123258 | Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells |
| Q90675908 | Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection |
| Q35583908 | Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques |
| Q34065709 | Microorganisms in the aetiology of atherosclerosis. |
| Q33762099 | Molecular mediators of arterial inflammation: a role for microbial products? |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q24633440 | PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 |
| Q40622718 | Porphyromonas gingivalis induces murine macrophage foam cell formation |
| Q37871590 | Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease |
| Q35272942 | Regulation of chlamydial infection by host autophagy and vacuolar ATPase-bearing organelles. |
| Q36354484 | The Chlamydia trachomatis CT149 protein exhibits esterase activity in vitro and catalyzes cholesteryl ester hydrolysis when expressed in HeLa cells |
| Q33429029 | The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection |
| Q37851226 | The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966. |
| Q35002280 | The link between periodontal disease and cardiovascular disease: How far we have come in last two decades ? |
| Q37876418 | The role of chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response |
| Q74310027 | [Infections and arteriosclerosis: science or fiction?] |
| Q37874954 | cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection |